Regulatory T Cells Immunosuppression and the Infusion of Anemia Is Ameliorated by Minor Antigen H 60-Mediated Aplastic

[1]  K. Rezvani,et al.  FOXP3-Positive Regulatory T-Cells in Acquired Aplastic Anemia. , 2006 .

[2]  N. Young,et al.  Current concepts in the pathophysiology and treatment of aplastic anemia. , 2006, Blood.

[3]  K. Rezvani,et al.  High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. , 2006, Blood.

[4]  J. Shimizu,et al.  Control of Autoimmune Myocarditis and Multiorgan Inflammation by Glucocorticoid-Induced TNF Receptor Family-Related Proteinhigh, Foxp3-Expressing CD25+ and CD25− Regulatory T Cells1 , 2006, The Journal of Immunology.

[5]  S. Ziegler,et al.  Adaptive Islet-Specific Regulatory CD4 T Cells Control Autoimmune Diabetes and Mediate the Disappearance of Pathogenic Th1 Cells In Vivo1 , 2006, The Journal of Immunology.

[6]  L. Harrison,et al.  Intranasal Vaccination with Proinsulin DNA Induces Regulatory CD4+ T Cells That Prevent Experimental Autoimmune Diabetes1 , 2006, The Journal of Immunology.

[7]  D. Glass,et al.  CD4+CD25+ T Cells Prevent the Development of Organ-Specific Autoimmune Disease by Inhibiting the Differentiation of Autoreactive Effector T Cells , 2005, The Journal of Immunology.

[8]  J. Ritz,et al.  Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. , 2005, Blood.

[9]  L. Luzzatto,et al.  Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors. , 2005, Blood.

[10]  C. Martínez-A,et al.  CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. , 2005, Blood.

[11]  B. Prabhakar,et al.  IL-10-Producing CD4+CD25+ Regulatory T Cells Play a Critical Role in Granulocyte-Macrophage Colony-Stimulating Factor-Induced Suppression of Experimental Autoimmune Thyroiditis1 , 2005, The Journal of Immunology.

[12]  C. Chapman,et al.  Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation. , 2005, Transplantation.

[13]  Jiang Zhu,et al.  Alloreactive Memory T Cells Are Responsible for the Persistence of Graft-versus-Host Disease1 , 2005, The Journal of Immunology.

[14]  S. Miller,et al.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.

[15]  Catherine J. Wu,et al.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. , 2004, Blood.

[16]  Jichun Chen,et al.  A mouse model of lymphocyte infusion-induced bone marrow failure. , 2004, Experimental hematology.

[17]  Jichun Chen,et al.  Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure. , 2004, Blood.

[18]  M. Shlomchik,et al.  Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. , 2004, Blood.

[19]  D. Jain,et al.  Donor APCs are required for maximal GVHD but not for GVL , 2004, Nature Medicine.

[20]  N. Young,et al.  In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing , 2004, The Lancet.

[21]  P. Pandolfi,et al.  GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease , 2004, The Journal of experimental medicine.

[22]  J. Ritz,et al.  Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation , 2004, The Journal of experimental medicine.

[23]  C. Craddock,et al.  Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. , 2004, Blood.

[24]  A. Kaplan,et al.  CD4+ T Cells Mediate Murine Syngeneic Graft-versus-Host Disease-Associated Colitis1 , 2004, The Journal of Immunology.

[25]  Stephen C. Jones,et al.  Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  F. Appelbaum,et al.  Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. , 2004, Blood.

[27]  Stephen C. Jones,et al.  Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model. , 2003, The Journal of clinical investigation.

[28]  L. Chatenoud,et al.  Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Danilenko,et al.  The role of interferon‐γ, nitric oxide and lipopolysaccharide in intestinal graft‐versus‐host disease developing in F1‐hybrid mice , 2003 .

[30]  D. Kaufman.  Murder mysteries in type 1 diabetes , 2003, Nature Medicine.

[31]  S. Malarkannan,et al.  Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease. , 2002, Blood.

[32]  Å. Lernmark,et al.  Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? , 2002, Springer Seminars in Immunopathology.

[33]  J. Kochenderfer,et al.  Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. , 2002, Blood.

[34]  Eun Young Choi,et al.  Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. , 2002, Immunity.

[35]  D. Follmann,et al.  Intracellular interferon-γ in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia , 2002 .

[36]  C. Fathman,et al.  Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.

[37]  L. Lanier,et al.  Cutting Edge: The Minor Histocompatibility Antigen H60 Peptide Interacts with Both H-2Kb and NKG2D1 , 2002, The Journal of Immunology.

[38]  N. Young,et al.  Limited heterogeneity of T cell receptor BV usage in aplastic anemia. , 2001, The Journal of clinical investigation.

[39]  N. Shastri,et al.  Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others , 2001, The Journal of Immunology.

[40]  M. Atkinson,et al.  The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.

[41]  N. Shastri,et al.  The molecular and functional characterization of a dominant minor H antigen, H60. , 1998, Journal of immunology.

[42]  R. Korngold,et al.  Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease. , 1998, Journal of immunology.

[43]  V. Tuohy,et al.  A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease , 1996, The Journal of experimental medicine.